Swedish Orphan Biovitrum AB (publ), an integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haematology, immunology, and genetic and metabolic diseases in Europe, North America, and internationally. It offers Alprolix for haemophilia B; Doptelet treatment of thrombocytopenia; Elocta for haemophilia A; Gamifant for hemophagocytic lymphohistiocytosis(HLH); Kineret for cryopyrin associated periodic syndrome, rheumatoid arthritis, and still's disease; Orfadin to treat hereditary tyrosinaemia type-1; and Synagis for serious lower respiratory tract infection. The company It also provides other products, such as Akynzeo, Aloxi, Ammonul, Betapred, Caphosol, Fibclot, IVheBex, and Willfact. In addition, it develops drug substance for ReFacto AF/Xyntha for Pfizer; BIVV001 for haemophilia A; and Nirsevimab for respiratory syncytial virus. The company has a strategic collaboration with Apellis Pharmaceuticals Inc. to develop pegcetacoplan for the treatment of multiple rare diseases, including paroxysmal nocturnal hemoglobinuria. Swedish Orphan Biovitrum AB (publ) is headquartered in Solna, Sweden. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Swedish Orphan Biovitrum.
Swedish Orphan Biovitrum business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Swedish Orphan Biovitrum are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Swedish Orphan Biovitrum , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Swedish Orphan Biovitrum including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Swedish Orphan Biovitrum and all latest updates of the company are provided.
The 2025 version of Swedish Orphan Biovitrum report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Swedish Orphan Biovitrum- Key Facts
2.2 Swedish Orphan Biovitrum- Geographic Locations
2.3 Swedish Orphan Biovitrum- Subsidiaries and Affiliates
2.4 Swedish Orphan Biovitrum- Business Divisions
2.5 Swedish Orphan Biovitrum- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Swedish Orphan Biovitrum Strategic Analysis Review
3.1 Swedish Orphan Biovitrum- Key Strategies
3.2 Swedish Orphan Biovitrum- Company Outlook Statement
3.3 Swedish Orphan Biovitrum- SWOT Analysis
3.3.1 Swedish Orphan Biovitrum- Key Strengths
3.3.2 Swedish Orphan Biovitrum- Key Weaknesses
3.3.3 Swedish Orphan Biovitrum- Potential Opportunities
3.3.4 Swedish Orphan Biovitrum- Potential Threats
3.4 Swedish Orphan Biovitrum- Key Competitors
4. Business Description of the Company
4.1 Swedish Orphan Biovitrum- Business Overview
4.2 Swedish Orphan Biovitrum- Operations by Segment
5 Products and Services Details
5.1 Swedish Orphan Biovitrum- Key Products
5.2 Swedish Orphan Biovitrum- Key Service Areas
5.3 Swedish Orphan Biovitrum- Key Brands
6 Company Developments
6.1 Swedish Orphan Biovitrum- Company History
6.2 Swedish Orphan Biovitrum- Latest Developments
7 Financial Analysis
7.1 Swedish Orphan Biovitrum- Income Statements
7.2 Swedish Orphan Biovitrum- Balance Sheet
7.3 Swedish Orphan Biovitrum- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Swedish Orphan Biovitrum- Direct Competitors
8.2 Swedish Orphan Biovitrum- Competitor Financial Ratios comparison
8.3 Swedish Orphan Biovitrum- Competitor Stock Charts Comparison
8.4 Swedish Orphan Biovitrum- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!